- Filed
- Feb 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Feb 13, 2025 | 29.59M sh |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $849.93K |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $824.25K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.43M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $5.43M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 29.66M sh |
| Capex | Q1 2025 · Dec 31, 2023 | $5.18K |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | −$355.94K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.77M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $2.85M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $0.00 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $0.00 |
| Sga Expense restated | Q1 2025 · Dec 31, 2023 | $1.15K |
| Net Income | Q1 2025 · Dec 31, 2023 | −$88.31K |
| Operating Income restated | Q1 2025 · Dec 31, 2023 | −$169.29K |